Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows a new revision tag Revision: v3.5.4 in place of the previous Revision: v3.5.3. This indicates a minor update to the study record's documentation on ClinicalTrials.gov.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA small change in the page’s site revision/version indicator, updating it from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 on the page; no evident changes to study details or related information.SummaryDifference0.1%

- Check65 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3; no changes to study content are visible.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 released, replacing v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.